Senolytic Therapeutics (STX) is a pharmaceutical company that develops a novel class of medicines by targeting damaged cells.
STX’s mission is to advance our portfolio of therapies to clinical trials and improve human condition.
We are challenged above all by the opportunity to improve the lives of patients and families affected by aging-associated diseases.
STX company is located in Boston (US) and Barcelona (Spain).
Company Details
- Employees
- 2
- Address
- Barcelona Science Park, Barcelona,barcelona 08028,spain
- Phone
- 34607046707
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- senolytx.com
- Keywords
- Avizorex Pharma.
- HQ
- Barcelona, Barcelona
Senolytic Therapeutics Questions
Senolytic Therapeutics's helpline number is 34607046707
Senolytic Therapeutics's website is senolytx.com
Senolytic Therapeutics's LinkedIn profile is https://es.linkedin.com/company/senolytic-therapeutics
Senolytic Therapeutics has
2 employees.
View email and phone details for 2
employees at Senolytic Therapeutics.
Senolytic Therapeutics's industry is
Pharmaceutical Manufacturing
Senolytic Therapeutics's top competitors are
Rejuversen,
Syna Therapeutics,
Agomab,
Aptadel Therapeutics,
Certifydoc,
Avizorex Pharma, S.l.,
Centenara Labs Ag,
Rejuvenate Biomed,
Ninevah Therapeutics,
Added Health™.
Senolytic Therapeutics's categories are Pharmaceutical Manufacturing
